Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.4218 | 79 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.51872 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.39118 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.16126 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.22568 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.47011 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.78058 | 82 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.37189 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.18934 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.3822 | 78 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.35501 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.47243 | 78 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.38802 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.32277 | 78 |